<DOC>
	<DOCNO>NCT01076517</DOCNO>
	<brief_summary>To provide Therasphere treatment patient diagnose unresectable liver cancer .</brief_summary>
	<brief_title>A Humanitarian Device Exemption Treatment Protocol TheraSphere For Treatment Unresectable Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>Patients age , race sex , hepatocellular carcinoma liver , able give inform consent , eligible . Patients must ECOG Performance Status score &lt; /= 2 , life expectancy &gt; /= 3 month , nonpregnant acceptable contraception premenopausal woman . Patients must &gt; 4 week since prior radiation prior surgery least 1 month post chemotherapy . Contraindications angiography selective visceral catheterization Evidence potential delivery great 16.5 mCi ( 30 Gy absorb dose ) radiation lung Evidence detectable Tc99m MAA flow stomach duodenum , application establish angiographic technique stop mitigate flow ( ex . place catheter distal gastric vessel ) Significant extrahepatic disease represent imminent lifethreatening outcome Severe liver dysfunction pulmonary insufficiency Active uncontrolled infection Significant underlying medical psychiatric illness Pregnancy Patients exclude : comorbid disease acute chronic condition would preclude safe delivery TheraSphere treatment place patient undue risk .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>